SwissINSO Holding Inc. SWHN Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Oct 1, 2013 at 6:08 PM

SwissINSO Holding Inc. SWHN Company Overview

Stock Message Board http://investorshangout.com/search?q=SWHN&...mp;yt1=Go!

SwissINSO Holding Inc. SWHN Current Price and Quotes
Last Price 0.065
Previous Close 0.05 Open 0.065
Daily Range 0.065 - 0.065 52wk Range 0.07 - 0.01
Volume 1,000 Dividend N/A
Average Vol (3m) 15,194 Yield N/A
SwissINSO Holding Inc. SWHN
Company Information

PSE – Parc Scientifique de l’EPFL
Route J.D. Colladon
Building D, 3rd Floor
Lausanne 1015
Switzerland

Phone: 011-41-21-693-8640

SwissINSO Holding Inc. SWHN
SwissINSO Holding Inc. SWHN
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001437395
Fiscal Year End 5/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 5621 - Womens clothing stores
Incorporated In: DE, USA
Year of Inc. 2007
Employees Not Available
Company Officers/Contacts

Rafic Hanbali President
Frederic Stritt CEO
Clive D. Harbutt Interim CFO
Company Directors

Rafic Hanbali Chairman
Suhail Konstantin Saad
Company Notes

Formerly=Pashminadepot.com, Inc. until 11-2009
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

SwissINSO Holding Inc. SWHN
SWHN Security Details

Share Structure

Market Value1 $6,723,266 a/o Sep 30, 2013
Shares Outstanding 134,465,321 a/o Aug 19, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders

Shareholders of Record 51 a/o Apr 16, 2013
Security Notes

Capital Change=shs increased by 10 for 1 split. Ex-date=03/30/2009. Rec date=03/24/2009. Pay date=03/27/2009.
Short Selling Data

Short Interest 0 (-100%)
Oct 14, 2011
Significant Failures to Deliver No
Transfer Agent(s)

Broadridge Financial Solutions, Inc.

SwissINSO Holding Inc. SWHN Recent News

SwissINSO Holding Inc. SWHN Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 171 180 288 650
Sales, General and Admin. 2,689 57 5,288 3,864
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,859) (237) (5,576) (4,514)
Income From Continuing Operations

Add'l Income/Expense Items - - (5) 7
Earnings Before Interest and Tax (2,859) (237) (5,581) (4,507)
Interest Expense 442 462 400 25
Earnings Before Tax (3,301) (699) (5,980) (4,532)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,301) (699) (5,980) (4,532)
Non Recurring Events

Discontinued Operations (26) - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,327) (699) (5,980) (4,532)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,327) (699) (5,980) (4,532)

SWHN SwissINSO Holding Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=SWHN&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SWHN/quote
Stock Chart http://www.otcmarkets.com/stock/SWHN/chart
Company Info http://www.otcmarkets.com/stock/SWHN/company-info
Recent News http://www.otcmarkets.com/stock/SWHN/news
Financials http://www.otcmarkets.com/stock/SWHN/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SWHN/filings
Short Sales http://www.otcmarkets.com/stock/SWHN/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SWHN/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SWHN/research
Summary http://finance.yahoo.com/q?s=SWHN
Historical Prices http://finance.yahoo.com/q/hp?s=SWHN+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SWHN
Basic Chart http://finance.yahoo.com/q/bc?s=SWHN+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SWHN+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SWHN+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SWHN+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SWHN+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SWHN+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SWHN+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SWHN+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SWHN+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SWHN+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SWHN
Balance Sheet http://finance.yahoo.com/q/bs?s=SWHN
Cash Flow http://finance.yahoo.com/q/cf?s=SWHN+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SWHN
Market Watch http://www.marketwatch.com/investing/stock/SWHN
Bloomberg http://www.bloomberg.com/quote/SWHN:US
Morningstar http://quotes.morningstar.com/stock/s?t=SWHN
Bussinessweek http://investing.businessweek.com/research/st...icker=SWHN
Barchart http://www.barchart.com/quotes/stocks/SWHN
OTC Short Report http://otcshortreport.com/index.php?index=SWHN
Investopedia http://www.investopedia.com/markets/stocks/SWHN/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...